Related Experiment Video
Updated: Mar 22, 2026

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Genome instability in Alzheimer disease
Yujun Hou1, Hyundong Song1, Deborah L Croteau1
1Laboratory of Molecular Gerontology, National Institute on Aging, NIH, Baltimore, MD 21224, USA.
Genome instability and DNA repair issues are linked to Alzheimer's disease (AD) pathology. Understanding these connections may lead to new treatments for this neurodegenerative disorder.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia.
- Familial AD (fAD) results from specific gene mutations, while sporadic AD (sAD) involves complex genetic risk factors.
- DNA integrity is crucial for neuronal function, and damage/repair alterations are implicated in aging and neurodegeneration.
Purpose of the Study:
- To provide an overview of genome instability and DNA repair deficiency in AD pathology.
- To discuss research strategies focusing on genome instability in AD.
- To explore novel mechanisms linking DNA damage to neuronal dysfunction in AD.
Main Methods:
- Review of existing research on DNA damage and repair in Alzheimer's disease.
- Analysis of findings from animal models of AD and DNA repair deficiency.
- Identification of novel molecular mechanisms connecting DNA damage to AD.
Main Results:
- Genome instability and impaired DNA repair are implicated in Alzheimer's disease pathogenesis.
- Research using animal models supports the link between DNA damage and AD.
- Novel mechanisms connecting DNA damage to neuronal dysfunction have been identified.
Conclusions:
- Genome instability and DNA repair deficiency play a significant role in Alzheimer's disease.
- Further investigation into these molecular mechanisms could yield novel therapeutic strategies for AD.
- Incorporating genome instability into research strategies may advance understanding and treatment of AD.
More Related Videos
11:57Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase
Published on: June 24, 2025
04:22Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Microtubule Instability
Alzheimer's Disease: Treatment
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...